特集 神経疾患治療の進歩2021
Parkinson病及び関連疾患の治療の進歩（2021）
2022 年 39 巻 5 号 p. 768-772
詳細
2022 年 39 巻 5 号 p. 768-772
We review reports published in 2021 providing new information on the management of Parkinson disease (PD) and its related disorder. Several clinical trials of drugs for disease–modifying therapy (DMT) are also underway, but no drug has yet been reported that has clearly demonstrated efficacy in either PD or secondary parkinsonism.
